A postinfluenza model of Staphylococcus aureus pneumonia.

BACKGROUND Postinfluenza Staphylococcus aureus pneumonias are increasingly recognized as a major form of life-threatening infections. METHODS A mouse model of postinfluenza S. aureus pneumonia was developed. Mice were intranasally infected with bacteria alone or bacteria plus virus. Infection was assessed by mouse survival, lung histopathology, bacterial density in the lungs, and cellular response to infection. RESULTS Mice infected with both influenza virus and S. aureus showed higher mortality, greater lung parenchymal damage, and greater bacterial density at metastatic tissue sites than mice infected with only S. aureus. At 4 h, more polymorphonuclear leukocytes and fewer CD11c(+) cells were found in lung samples from mice infected with virus and bacteria than in those from mice infected with bacteria. alpha-Hemolysin and protein A were maximally expressed 4 h after infection, and Panton-Valentine leukocidin was maximally expressed 72 h after infection, with higher levels of alpha-hemolysin expression in mice infected with bacteria alone. Interferon gamma expression was higher in tissue collected from mice infected with virus plus bacteria than in those from bacteria-infected mice. CONCLUSIONS The results from this model demonstrate diverse effects caused by antecedent influenza virus infection, which have a profound influence on the morbidity and mortality associated with S. aureus pneumonia.

[1]  N. Masurel,et al.  Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. , 1958, Lancet.

[2]  T. F. Smith,et al.  Replication and plaque assay of influenza virus in an established line of canine kidney cells. , 1968, Applied microbiology.

[3]  D. Levy,et al.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.

[4]  D. Lauderdale,et al.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. , 1998, JAMA.

[5]  F. Vandenesch,et al.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  S. Szmigielski,et al.  Leukocidal toxins of staphylococci. , 1999, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[7]  H. Chambers,et al.  The changing epidemiology of Staphylococcus aureus? , 2001, Emerging infectious diseases.

[8]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[9]  Roger E Bumgarner,et al.  Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Rehg,et al.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. , 2002, The Journal of infectious diseases.

[11]  J. McCullers,et al.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. , 2003, The Journal of infectious diseases.

[12]  R. Novick Autoinduction and signal transduction in the regulation of staphylococcal virulence , 2003, Molecular microbiology.

[13]  Mian Cai,et al.  Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Boyce,et al.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat , 2006, The Lancet.

[15]  C. Bridges,et al.  Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season , 2006, Emerging infectious diseases.

[16]  O. Schneewind,et al.  Surface Proteins and Exotoxins Are Required for the Pathogenesis of Staphylococcus aureus Pneumonia , 2006, Infection and Immunity.

[17]  Adeline R. Whitney,et al.  Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? , 2006, The Journal of infectious diseases.

[18]  J. McCullers Insights into the Interaction between Influenza Virus and Pneumococcus , 2006, Clinical Microbiology Reviews.

[19]  J. Brundage Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness , 2006, The Lancet Infectious Diseases.

[20]  Anthony S Fauci,et al.  The 1918 influenza pandemic: insights for the 21st century. , 2007, The Journal of infectious diseases.

[21]  E. Delong,et al.  Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia , 2007, Science.

[22]  O. Schneewind,et al.  Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia , 2007, Nature Medicine.

[23]  P. Polgreen,et al.  Characteristics of Staphylococcus aureus community-acquired pneumonia during the 2006-2007 influenza season. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  D. Metzger,et al.  Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection , 2008, Nature Medicine.

[25]  L. Brammer,et al.  Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection , 2008, Pediatrics.

[26]  Adeline R. Whitney,et al.  Contribution of Panton-Valentine Leukocidin in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis , 2008, PloS one.

[27]  R. Thrall,et al.  Inhalation of Staphylococcus aureus Enterotoxin A Induces IFN-γ and CD8 T Cell-Dependent Airway and Interstitial Lung Pathology in Mice1 , 2008, The Journal of Immunology.

[28]  D. Kasper,et al.  IFN-γ Regulated Chemokine Production Determines the Outcome of Staphylococcus aureus Infection1 , 2008, The Journal of Immunology.

[29]  Anthony S Fauci,et al.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. , 2008, The Journal of infectious diseases.

[30]  A. Husain,et al.  Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. , 2008, The Journal of infectious diseases.

[31]  G. Dennis Shanks,et al.  Deaths from Bacterial Pneumonia during 1918–19 Influenza Pandemic , 2008, Emerging infectious diseases.

[32]  M. Holtzman,et al.  Airway Epithelial versus Immune Cell Stat1 Function for Innate Defense against Respiratory Viral Infection1 , 2008, The Journal of Immunology.

[33]  A. Shahangian,et al.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. , 2009, The Journal of clinical investigation.

[34]  Francis J. Martin,et al.  Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. , 2009, The Journal of clinical investigation.

[35]  R. Daum,et al.  Transcription of Inflammatory Genes in the Lung after Infection with Community-Associated Methicillin-Resistant Staphylococcus aureus: a Role for Panton-Valentine Leukocidin? , 2009, Infection and Immunity.